Form D · Other Health Care

RxInnovation Inc.

Fort Worth, TX · CIK 0001557336

Offering snapshot reported Sep 5, 2014 · SEC filing

Reported sold: $9.54M
Investors reported: 5
Minimum accepted: $0
First sale: Aug 27, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$7,865,646 → $9,540,646

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 5, 2014	Amendment	$9,540,646	$1,675,000vs Sep 5, 2013	5	SEC filing
Sep 5, 2013	Amendment	$7,865,646	$0vs Sep 6, 2012	5	SEC filing
Sep 6, 2012	Initial	$7,865,646	No comparison	5	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-183753

Source: Form D, filed Sep 5, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Michael Booth	Director, Executive
Richard Bukovinsky	Director, Executive
Jacob Canova	Director, Executive
Peter Fianu	Director, Executive
Josh Hall	Director
Brandon Halm	Executive
Brian Mahoney	Director
Harlan Seymour	Director
John Wissel	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

2601 Scott Avenue Suite 600
Fort Worth, TX, 76103